Drug Discovery Startup Engine Biosciences Raises $10M

Jan 31, 2018

|

NEW YORK (GenomeWeb) – Drug discovery startup Engine Biosciences announced today that it has raised $10 million in seed funding.

The oversubscribed round was co-led by Danhua Capital and 6 Dimensions Capital, and included WuXi AppTec, EDBI, Pavilion Capital, Baidu Ventures, WI Harper, and Nest Bio Ventures.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Swabs for Science of Spread

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

Genome of the Murder Hornet

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

In a Pool Together

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

Science Presents Paper on Computational Method to Predict IBD Patient Response to Therapy

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

From Synthetic Gene to Vaccine: Confidence with GeneArt Gene Synthesis Services A GenomeWeb eCase Study Transcript

Harnessing the Power of the Expi Protein Expression Systems in Vaccine Development A GenomeWeb eCase Study Transcript

Generating Accurate and Contiguous De Novo Genome Assemblies Using Hybrid Scaffolding

Aug

19

Featured Webinar

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Aug

24

Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Sep

03

Featured Webinar

Implementation of Preemptive PGx Screening in a World-Class Personalized Medicine Program

This webinar will provide an overview of how the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado implemented a preemptive pharmacogenomic screening program via a large-scale research biobank and a robust biocomputing system.

Sep

10

Featured Webinar

Development of RNA-Based Predictive Response Signatures as Companion Diagnostics

This webinar, Part 2 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will focus on the development of RNA-based companion diagnostics for oncology.

Menu

Drug Discovery Startup Engine Biosciences Raises $10M

To read the full story....

Breaking News

Guardant Health CDx Wins FDA Approval for First Liquid Biopsy NGS Tumor Profiling Assay

Researchers Use CRISPR-Cas13 Platform to Interrogate Gene Function in Animal Embryos

New Products Posted to GenomeWeb: Illumina, Adaptive Biotechnologies, Personalis, More

In Brief This Week: ArcherDx, NanoString Technologies, the Cleveland Clinic, and More

Bruker, Utrecht University Partnering on Mass Spec Methods

People in the News: New Appointments at Pacific Biosciences, Lexogen, Tangen Biosciences, More

The Scan

Swabs for Science of Spread

Genome of the Murder Hornet

In a Pool Together

Science Presents Paper on Computational Method to Predict IBD Patient Response to Therapy

Featured White Papers

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

Utility of Novel RNA-Based Tools in Oncology Drug Development

Implementation of Preemptive PGx Screening in a World-Class Personalized Medicine Program

Development of RNA-Based Predictive Response Signatures as Companion Diagnostics

What's Popular?

Computational Tool Analyzes Noncoding Mutations to Classify Cancer Subtypes

Fulgent Genetics Touts Returns on COVID-19 Testing Investment

Sponsorships